Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Glenn Deng"'
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 4 (2016)
Increasing evidence shows that the heterogeneity of individual cells within a genetically identical population can be critical to their peculiar function and fate. Conventional cell based assays mainly analysis the average responses from a population
Externí odkaz:
https://doaj.org/article/04794f0d0e164ee4a044bdddddb6daf0
Autor:
Alan Dafforn, Pengchin Chen, Glenn Deng, Michael Herrler, Dawn Iglehart, Sriveda Koritala, Susan Lato, Susheela Pillarisetty, Reshma Purohit, Martin Wang, Shenglong Wang, Nurith Kurn
Publikováno v:
BioTechniques, Vol 37, Iss 5, Pp 854-857 (2004)
Gene expression analysis has become an invaluable tool for understanding gene function and regulation. However, global expression analysis requires large RNA quantities or RNA preamplification. We describe an isothermal messenger RNA (mRNA) amplifica
Externí odkaz:
https://doaj.org/article/a919980eb9ca4de0b960ec6a2259991b
Autor:
Ashley A Powell, Amirali H Talasaz, Haiyu Zhang, Marc A Coram, Anupama Reddy, Glenn Deng, Melinda L Telli, Ranjana H Advani, Robert W Carlson, Joseph A Mollick, Shruti Sheth, Allison W Kurian, James M Ford, Frank E Stockdale, Stephen R Quake, R Fabian Pease, Michael N Mindrinos, Gyan Bhanot, Shanaz H Dairkee, Ronald W Davis, Stefanie S Jeffrey
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e33788 (2012)
To improve cancer therapy, it is critical to target metastasizing cells. Circulating tumor cells (CTCs) are rare cells found in the blood of patients with solid tumors and may play a key role in cancer dissemination. Uncovering CTC phenotypes offers
Externí odkaz:
https://doaj.org/article/a771b86c1e284f36b531777943ccdb2b
Autor:
Stefanie S. Jeffrey, Glenn Deng
Publikováno v:
Cancer Research. 79:1031-1031
Tumor cells face the enviormental changes when leave tumor tissue enter into bloodstream. The environmental changes stimulate tumor cells to adapt the new enviorments with cell functional changes. Epithelial to mesenchymal transition (EMT) is well kn
Autor:
Yalin Xu, Yang Liu, Qiao Huang, Glenn Deng, Xin-Hua Xu, Ming-Qian Lu, Li Yang, Daojun Li, Haibo Zhou, Rong Guo
Publikováno v:
Oncology Letters.
Downregulation of microRNA-34a (miR-34a) has frequently been observed in esophageal squamous cell carcinoma (ESCC). However, the underlying role and molecular mechanism of miR-34a in ESCC remains largely unknown. In the current study, it was demonstr
Autor:
Glenn Deng1,2 glenn_deng@yahoo.com, Krishnakumar, Sujatha3, Powell, Ashley A.2,4, Haiyu Zhang2,5, Mindrinos, Michael N.3, Telli, Melinda L.6, Davis, Ronald W.3, Jeffrey, Stefanie S.2 ssj@stanford.edu
Publikováno v:
BMC Cancer. 6/19/2014, Vol. 14, p1-12. 12p. 1 Color Photograph, 2 Diagrams, 4 Charts, 1 Graph.
Autor:
Glenn Deng
Publikováno v:
Archives in Cancer Research.
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 4 (2016)
Frontiers in Cell and Developmental Biology, Vol 4 (2016)
Increasing evidence shows that the heterogeneity of individual cells within a genetically identical population can be critical to their peculiar function and fate. Conventional cell based assays mainly analysis the average responses from a population
Autor:
Martin Junhong Wang, Glenn Deng, Sairam V. Jabba, Philine Wangemann, Nurith Kurn, Joe Don Heath, Rajanikanth J Maganti, Ruchira Singh
Publikováno v:
American Journal of Physiology-Cell Physiology. 288:C1179-C1189
Gene expression profiling using microarrays requires microgram amounts of RNA, which limits its direct application for the study of nanogram RNA samples obtained using microdissection, laser capture microscopy, or needle biopsy. A novel system based
Autor:
Ronald W. Davis, Glenn Deng, Melinda L. Telli, Haiyu Zhang, Michael N. Mindrinos, Ashley A. Powell, Stefanie S. Jeffrey, Sujatha Krishnakumar
Publikováno v:
BMC Cancer
Background Therapeutic decisions in cancer are generally guided by molecular biomarkers or, for some newer therapeutics, primary tumor genotype. However, because biomarkers or genotypes may change as new metastases emerge, circulating tumor cells (CT